Skip to content
value.today

Pfizer Inc.: timeline

Every dated event on file, newest first: history, results, dividends, splits, index changes, insider trades, layoffs and recalls, each with its source.

140 events

On the market-cap history; source: Market-cap history on value.today.

$152.7 B$232.7 B$312.8 B202120222023202420252026Nov 3, 2026: Results releasedSep 2026: 2 recalls reported to Drugs (FDA)Aug 12, 2026: 3 insiders bought $3.0 million of shares on the marketAug 4, 2026: Results releasedJun 28, 2026: Dividend of $0.86 a shareMay 5, 2026: Results releasedFeb 26, 2026: Annual report filed (Form 10-K)Feb 3, 2026: Results releasedDec 31, 2025: Dividend of $0.86 a shareNov 4, 2025: Results releasedAug 5, 2025: Results releasedAug 4, 2025: Recall: Vial Label: Epinephrine Injection, USP, 1mg/10mL (0.1 mg/mL), Rx only, Distributed by Hospira, Inc., Lake Forest, IL 600Jul 2025: 2 recalls reported to Drugs (FDA)Jun 29, 2025: Dividend of $0.86 a shareMay 28, 2025: Recall: DOBUTamine Injection, USP, 250 mg/20 mL (12.5 mg/mL), 20 mL per Single-dose Vial, carton of 10 Fliptop Vials, Rx only, FApr 29, 2025: Results releasedApr 29, 2025: RestructuringApr 4, 2025: Layoff: 56 employees in San Diego, CAFeb 27, 2025: Annual report filed (Form 10-K)Feb 13, 2025: 1 insider bought $499,072 of shares on the marketFeb 4, 2025: Results releasedDec 31, 2024: Dividend of $0.85 a shareOct 30, 2024: 1 insider bought $28,240 of shares on the marketOct 29, 2024: Results releasedJul 30, 2024: Results releasedJun 30, 2024: Dividend of $0.84 a shareMay 22, 2024: RestructuringMay 22, 2024: Restructuring plan: employeesMay 20, 2024: Recall: Labetalol Hydrochloride Injection, USP, 20 mg/4 mL (5 mg/mL), 4 mL Single-dose Carpuject, Sterile Cartridge Unit with LuMay 1, 2024: Results releasedJan 30, 2024: Results releasedDec 31, 2023: Dividend of $0.83 a shareDec 2023: 2 recalls reported to Drugs (FDA)Dec 15, 2023: 1 insider bought $79,410 of shares on the marketDec 15, 2023: Layoff: 52 employees in South San Francisco Research Facility South San Francisco, CADec 14, 2023: Results releasedOct 31, 2023: Results releasedOct 13, 2023: Results releasedOct 13, 2023: Restructuring plan: employeesOct 2, 2023: Recall: 2% Lidocaine HCl Injection, USP, 100mg/5mL(20mg/mL), Glass ABBOJECT Unit of Use Syringe, packaged as 1 vial and injectorAug 1, 2023: Results releasedJul 2, 2023: Dividend of $0.82 a shareMay 8, 2023: 1 insider bought $77,010 of shares on the marketMay 2, 2023: Results releasedMar 8, 2023: Recall: MEKTOVI (binimetinib) tablets, 15 mg, 180-count bottle, Rx only, Distributed by: Array BioPharma Inc., a wholly owned suFeb 9, 2023: Layoff: 196 employees in San Diego, CAJan 31, 2023: Results releasedDec 31, 2022: Dividend raised 2.5% to $0.41 a shareDec 2022: 2 recalls reported to Drugs (FDA)Nov 1, 2022: Results releasedOct 2, 2022: Dividend cut 50.0% to $0.4 a shareSep 27, 2022: Recall: Aminophylline Injection, USP 250 mg/10 mL (25 mg/mL) 25x10 mL Single-dose vial, Rx only, Distributed by Hospira, Inc. LaAug 22, 2022: Recall: PROPOFOL Injectable Emulsion, 1 g/100 mL (10 mg/mL), packaged in 100 mL glass fliptop vial (NDC 0409-4699-54) further paJul 28, 2022: Results releasedJul 13, 2022: Recall: Propofol Injectable Emulsion, 1 g/100 mL (10 mg/mL), packaged in 100 mL per glass fliptop vial (NDC 0409-4699-54) furtheJul 3, 2022: Dividend of $0.8 a shareMay 3, 2022: Results releasedApr 22, 2022: Recall: Accupril (Quinapril HCl Tablets) 10 mg, 90 Tablets Rx only NDC 0071-0530-23 Distributed by: Parke-Davis Division of PfizApr 20, 2022: Results releasedMar 21, 2022: Recall: quinapril and hydrochlorothiazide tablets, 20 mg/25 mg*, 90 Tablets bottles, Rx Only, Distributed by: Greenstone, LLC, PFeb 8, 2022: Results released2022: Revenue passed $100 billion2022: Record revenue of $101.2 billion2022: Record net income of $31.4 billionDec 31, 2021: Dividend raised 2.6% to $0.4 a shareNov 30, 2021: Recall: 5% Dextrose Injection, USP, 50 mL ADD-Vantage Unit, Rx only, Distributed by Hospira, INC., Lake Forest, IL 60045 USA, NDNov 2, 2021: Results releasedOct 3, 2021: Dividend cut 50.0% to $0.39 a shareAug 13, 2021: Recall: Chantix (varenicline) tablets 0.5mg, 56 Tablets, Rx only, Distributed by Pfizer Labs, Division of Pfizer Inc. NY, NY 100Jul 28, 2021: Results releasedJul 4, 2021: Dividend of $0.78 a shareJun 9, 2021: Recall: Chantix (varenicline) tablets, 0.5mg*, 56 Tablets, Rx Only, Distributed by Pfizer Labs, Division of Pfizer Inc., NY, NY May 4, 2021: Results releasedMay 2021: 2 recalls reported to Drugs (FDA)Dec 31, 2020: Dividend raised 2.6% to $0.39 a shareSep 27, 2020: Dividend cut 50.0% to $0.38 a shareAug 31, 2020: Removed from the Dow Jones Industrial AverageAug 6, 2020: 1 insider bought $501,085 of shares on the marketJul 20, 2020: Recall: Fentanyl Citrate Inj., USP 100 mcg Fentanyl/2 mL (50 mcg/mL) 2 mL Single-dose Fliptop Vials, Rx only, Distributed by HosJun 28, 2020: Dividend of $0.76 a shareMay 2020: 2 recalls reported to Drugs (FDA)Feb 2020: 3 recalls reported to Drugs (FDA)Jan 30, 2020: 1 insider bought $37,000 of shares on the market

Point at a marker under the line to see the event. Green: good news by its nature (a raise, an index entry), orange: bad (a cut, a layoff), grey: neither.

  1. 2026

    1. Nov 3, 2026
      Results released

      Form 8-K filed 03 Nov 2026

      Results releases · source: SEC EDGAR (Form 8-K, item 2.02)

    2. Sep 2026
      2 recalls reported to Drugs (FDA)

      Dopamine HCl Inj., USP, 200 mg/5 mL (40 mg/mL), 5 mL Single-; Levoxyl (levothyroxine sodium tablets, USP), tablets, 175 mc

      Product recalls · source: Drugs (FDA)

    3. Aug 12, 2026
      3 insiders bought $3.0 million of shares on the market

      Open-market purchases between 05 Aug and 12 Aug 2026

      Insider buying and large selling · source: SEC Forms 4 and 5

    4. Aug 4, 2026
      Results released

      Form 8-K filed 04 Aug 2026

      Results releases · source: SEC EDGAR (Form 8-K, item 2.02)

    5. Jun 28, 2026
      Dividend of $0.86 a share

      Quarter to 28 Jun 2026; the first on file

      Dividend raises and cuts · source: SEC filings (dividends declared per share)

    6. May 5, 2026
      Results released

      Form 8-K filed 05 May 2026

      Results releases · source: SEC EDGAR (Form 8-K, item 2.02)

    7. Feb 26, 2026
      Annual report filed (Form 10-K)

      For the year to 31 Dec 2025

      Annual reports · source: SEC EDGAR (10-K, 20-F, 40-F)

    8. Feb 3, 2026
      Results released

      Form 8-K filed 03 Feb 2026

      Results releases · source: SEC EDGAR (Form 8-K, item 2.02)

  2. 2025

    1. Dec 31, 2025
      Dividend of $0.86 a share

      Quarter to 31 Dec 2025; the first on file

      Dividend raises and cuts · source: SEC filings (dividends declared per share)

    2. Nov 4, 2025
      Results released

      Form 8-K filed 04 Nov 2025

      Results releases · source: SEC EDGAR (Form 8-K, item 2.02)

    3. Aug 5, 2025
      Results released

      Form 8-K filed 05 Aug 2025

      Results releases · source: SEC EDGAR (Form 8-K, item 2.02)

    4. Aug 4, 2025
      Recall: Vial Label: Epinephrine Injection, USP, 1mg/10mL (0.1 mg/mL), Rx only, Distributed by Hospira, Inc., Lake Forest, IL 600

      49,620 vials

      Product recalls · source: Drugs (FDA)

    5. Jul 2025
      2 recalls reported to Drugs (FDA)

      Bicillin L-A (penicllin G benzathine injectable suspension),; Levoxyl (levothyroxine sodium tablets, USP), 50 mcg, 100-cou

      Product recalls · source: Drugs (FDA)

    6. Jun 29, 2025
      Dividend of $0.86 a share

      Quarter to 29 Jun 2025; the first on file

      Dividend raises and cuts · source: SEC filings (dividends declared per share)

    7. May 28, 2025
      Recall: DOBUTamine Injection, USP, 250 mg/20 mL (12.5 mg/mL), 20 mL per Single-dose Vial, carton of 10 Fliptop Vials, Rx only, F

      98,410 vials

      Product recalls · source: Drugs (FDA)

    8. Apr 29, 2025
      Results released

      Form 8-K filed 29 Apr 2025

      Results releases · source: SEC EDGAR (Form 8-K, item 2.02)

    9. Apr 29, 2025
      Restructuring

      A plan to exit or dispose of activities, usually with job cuts.

      Notable 8-K events · source: SEC EDGAR (Form 8-K)

    10. Apr 4, 2025
      Layoff: 56 employees in San Diego, CA

      Layoff Permanent

      Layoffs · source: State WARN notice

    11. Feb 27, 2025
      Annual report filed (Form 10-K)

      For the year to 31 Dec 2024

      Annual reports · source: SEC EDGAR (10-K, 20-F, 40-F)

    12. Feb 13, 2025
      1 insider bought $499,072 of shares on the market

      Open-market purchases between 13 Feb and 13 Feb 2025

      Insider buying and large selling · source: SEC Forms 4 and 5

    13. Feb 4, 2025
      Results released

      Form 8-K filed 04 Feb 2025

      Results releases · source: SEC EDGAR (Form 8-K, item 2.02)

  3. 2024

    1. Dec 31, 2024
      Dividend of $0.85 a share

      Quarter to 31 Dec 2024; the first on file

      Dividend raises and cuts · source: SEC filings (dividends declared per share)

    2. Oct 30, 2024
      1 insider bought $28,240 of shares on the market

      Open-market purchases between 30 Oct and 30 Oct 2024

      Insider buying and large selling · source: SEC Forms 4 and 5

    3. Oct 29, 2024
      Results released

      Form 8-K filed 29 Oct 2024

      Results releases · source: SEC EDGAR (Form 8-K, item 2.02)

    4. Jul 30, 2024
      Results released

      Form 8-K filed 30 Jul 2024

      Results releases · source: SEC EDGAR (Form 8-K, item 2.02)

    5. Jun 30, 2024
      Dividend of $0.84 a share

      Quarter to 30 Jun 2024; the first on file

      Dividend raises and cuts · source: SEC filings (dividends declared per share)

    6. May 22, 2024
      Restructuring

      A plan to exit or dispose of activities, usually with job cuts.

      Notable 8-K events · source: SEC EDGAR (Form 8-K)

    7. May 22, 2024
      Restructuring plan: employees

      Layoffs · source: SEC filing (8-K Item 2.05)

    8. May 20, 2024
      Recall: Labetalol Hydrochloride Injection, USP, 20 mg/4 mL (5 mg/mL), 4 mL Single-dose Carpuject, Sterile Cartridge Unit with Lu

      220,400 cartridges

      Product recalls · source: Drugs (FDA)

    9. May 1, 2024
      Results released

      Form 8-K filed 01 May 2024

      Results releases · source: SEC EDGAR (Form 8-K, item 2.02)

    10. Jan 30, 2024
      Results released

      Form 8-K filed 30 Jan 2024

      Results releases · source: SEC EDGAR (Form 8-K, item 2.02)

  4. 2023

    1. Dec 31, 2023
      Dividend of $0.83 a share

      Quarter to 31 Dec 2023; the first on file

      Dividend raises and cuts · source: SEC filings (dividends declared per share)

    2. Dec 2023
      2 recalls reported to Drugs (FDA)

      Bleomycin for Injection, USP, 15 units per vial, 1 single do; 4.2% Sodium Bicarbonate Injection, USP 5 mEq/10 mL (0.5 mEq/

      Product recalls · source: Drugs (FDA)

    3. Dec 15, 2023
      1 insider bought $79,410 of shares on the market

      Open-market purchases between 15 Dec and 15 Dec 2023

      Insider buying and large selling · source: SEC Forms 4 and 5

    4. Dec 15, 2023
      Layoff: 52 employees in South San Francisco Research Facility South San Francisco, CA

      Layoff Permanent

      Layoffs · source: State WARN notice

    5. Dec 14, 2023
      Results released

      Form 8-K filed 14 Dec 2023

      Results releases · source: SEC EDGAR (Form 8-K, item 2.02)

    6. Oct 31, 2023
      Results released

      Form 8-K filed 31 Oct 2023

      Results releases · source: SEC EDGAR (Form 8-K, item 2.02)

    7. Oct 13, 2023
      Results released

      Form 8-K filed 13 Oct 2023

      Results releases · source: SEC EDGAR (Form 8-K, item 2.02)

    8. Oct 13, 2023
      Restructuring plan: employees

      Layoffs · source: SEC filing (8-K Item 2.05)

    9. Oct 2, 2023
      Recall: 2% Lidocaine HCl Injection, USP, 100mg/5mL(20mg/mL), Glass ABBOJECT Unit of Use Syringe, packaged as 1 vial and injector

      3,200 vials

      Product recalls · source: Drugs (FDA)

    10. Aug 1, 2023
      Results released

      Form 8-K filed 01 Aug 2023

      Results releases · source: SEC EDGAR (Form 8-K, item 2.02)

    11. Jul 2, 2023
      Dividend of $0.82 a share

      Quarter to 02 Jul 2023; the first on file

      Dividend raises and cuts · source: SEC filings (dividends declared per share)

    12. May 8, 2023
      1 insider bought $77,010 of shares on the market

      Open-market purchases between 05 May and 08 May 2023

      Insider buying and large selling · source: SEC Forms 4 and 5

    13. May 2, 2023
      Results released

      Form 8-K filed 02 May 2023

      Results releases · source: SEC EDGAR (Form 8-K, item 2.02)

    14. Mar 8, 2023
      Recall: MEKTOVI (binimetinib) tablets, 15 mg, 180-count bottle, Rx only, Distributed by: Array BioPharma Inc., a wholly owned su

      1,926 Bottles

      Product recalls · source: Drugs (FDA)

    15. Feb 9, 2023
      Layoff: 196 employees in San Diego, CA

      Layoff Permanent

      Layoffs · source: State WARN notice

    16. Jan 31, 2023
      Results released

      Form 8-K filed 31 Jan 2023

      Results releases · source: SEC EDGAR (Form 8-K, item 2.02)

  5. 2022

    1. Dec 31, 2022
      Dividend raised 2.5% to $0.41 a share

      Quarter to 31 Dec 2022

      Dividend raises and cuts · source: SEC filings (dividends declared per share)

    2. Dec 2022
      2 recalls reported to Drugs (FDA)

      Vancomycin Hydrochloride for Injection, USP, 1.5 g/vial, Ste; Heparin Sodium 2,000, USP Units, per 1,000 mL (2 USP Units/m

      Product recalls · source: Drugs (FDA)

    3. Nov 1, 2022
      Results released

      Form 8-K filed 01 Nov 2022

      Results releases · source: SEC EDGAR (Form 8-K, item 2.02)

    4. Oct 2, 2022
      Dividend cut 50.0% to $0.4 a share

      Quarter to 02 Oct 2022

      Dividend raises and cuts · source: SEC filings (dividends declared per share)

    5. Sep 27, 2022
      Recall: Aminophylline Injection, USP 250 mg/10 mL (25 mg/mL) 25x10 mL Single-dose vial, Rx only, Distributed by Hospira, Inc. La

      103,150 10 mL vials

      Product recalls · source: Drugs (FDA)

    6. Aug 22, 2022
      Recall: PROPOFOL Injectable Emulsion, 1 g/100 mL (10 mg/mL), packaged in 100 mL glass fliptop vial (NDC 0409-4699-54) further pa

      5,390 vials

      Product recalls · source: Drugs (FDA)

    7. Jul 28, 2022
      Results released

      Form 8-K filed 28 Jul 2022

      Results releases · source: SEC EDGAR (Form 8-K, item 2.02)

    8. Jul 13, 2022
      Recall: Propofol Injectable Emulsion, 1 g/100 mL (10 mg/mL), packaged in 100 mL per glass fliptop vial (NDC 0409-4699-54) furthe

      54,000 vials

      Product recalls · source: Drugs (FDA)

    9. Jul 3, 2022
      Dividend of $0.8 a share

      Quarter to 03 Jul 2022; the first on file

      Dividend raises and cuts · source: SEC filings (dividends declared per share)

    10. May 3, 2022
      Results released

      Form 8-K filed 03 May 2022

      Results releases · source: SEC EDGAR (Form 8-K, item 2.02)

    11. Apr 22, 2022
      Recall: Accupril (Quinapril HCl Tablets) 10 mg, 90 Tablets Rx only NDC 0071-0530-23 Distributed by: Parke-Davis Division of Pfiz

      2079 bottles

      Product recalls · source: Drugs (FDA)

    12. Apr 20, 2022
      Results released

      Form 8-K filed 20 Apr 2022

      Results releases · source: SEC EDGAR (Form 8-K, item 2.02)

    13. Mar 21, 2022
      Recall: quinapril and hydrochlorothiazide tablets, 20 mg/25 mg*, 90 Tablets bottles, Rx Only, Distributed by: Greenstone, LLC, P

      2442 bottles

      Product recalls · source: Drugs (FDA)

    14. Feb 8, 2022
      Results released

      Form 8-K filed 08 Feb 2022

      Results releases · source: SEC EDGAR (Form 8-K, item 2.02)

    15. 2022
      Revenue passed $100 billion

      FY2022 revenue of $101.2 billion, up from $81.3 billion in FY2021.

      Company history · source: Financial years

    16. 2022
      Record revenue of $101.2 billion

      FY2022, the highest of the 18 years on record.

      Company history · source: Financial years

    17. 2022
      Record net income of $31.4 billion

      FY2022, the highest profit of the 19 years on record.

      Company history · source: Financial years

Share price moves are worked out where the site has the listing's daily prices from the exchange itself: India (NSE), Taiwan (TWSE, TPEx), Brazil (B3), Poland (GPW), Russia (MOEX), Hong Kong (HKEX) and Sri Lanka (CSE). US listings have no daily price source on the site yet.

Sources: company history from Wikidata, SEC EDGAR, GLEIF and the site's own tables; results releases from SEC EDGAR (Form 8-K, item 2.02); annual reports from SEC EDGAR (10-K, 20-F, 40-F); dividend raises and cuts from SEC filings (dividends declared per share); index changes from Index providers' announcements as listed on Wikipedia; insider buying and large selling from SEC Forms 4 and 5; notable 8-k events from SEC EDGAR (Form 8-K); layoffs from State WARN notices and SEC 8-K item 2.05; product recalls from NHTSA, CPSC and FDA. Recurring events go back 15 years; the company's history is shown in full. Dividends appear when the amount per share changed; insider selling when a month's sales reach $10 million or 0.01% of the company.